Mechanisms of Gram Negative Resistance -- Austin Morrison, PharmD
Austin Morrison, Antimicrobial Stewardship Pharmacist at Moffitt Cancer Center and Research Institute, presents a broad overview of gram negative resistance. Topics discussed include the basic mechanisms of resistance, the classification scheme for beta-lactamases, as well as more specific information regarding specific beta-lactamse groups. First discussed are the the Class C (Amp C) beta-lactamases, followed by the Carbapenem-resistant Enterobacterales (CRE) organisms, and then difficult to treat Pseudomonas aeruginosa (DTR). Several case studies are also presented to help understand the clinical effects and available treatment options for these resistance mechanisms. Stay in touch! Download our app on the iTunes store or find us below: Subscribe to our Youtube Channel: / idpodcasts Visit us on our webpage: http://www.idpodcasts.net Follow us on Facebook: / usfid Tweet to us: / idpodcasts

New Antimicrobials for Multidrug Resistant Organisms -- Harrison Bachmeier, PharmD

Infectious Diseases Grand Rounds: The ABCs of Beta-lactamase

Neutropenic Fever in the 21st Century -- Rod Quilitz, Pharm.D.

Stenotrophomonas maltophilia: The Silent Rise of a Superbug

The Basics of Antibiotic Resistance: Focus on Carbapenem-Resistant Enterobacteriaceae (CRE)

Classification of Bacteria (Antibiotics - Lecture 1)

Could soil from an ancient grave help solve the antibiotics crisis?

IDMythbusters: Evaluating Historical and Current Practice Patterns -- Parker Kaleo, PharmD

Bacteremia and Clinical Resistance

Gram Negative Resistance -- Part II, Therapeutics -- Mel O'Neal, Pharm.D

PrEPare for a PEPtalk -- Drew Wilson, Pharm.D.

Detection of carbapenemases - Editors in Conversation (JCM Edition)

Antibiotics

Rocky Mountain Highlights 2023 I Session I: High Yield Topics in Luminal Gastroenterology

Antibiotic Review: Beta Lactams - John Toney, MD

Carbapenem resistant Enterobacerales (CRE) are on the Rise! Webinar by Dr. Nathan Ledeboer, PhD.

Advances on Bacteriophage Therapy -- Jesus Diaz, MD

Antibiotic Resistance in Gram-Negative Bacteria: Treatment Challenges & New Options

ß-Lactams: Mechanisms of Action and Resistance

